Literature DB >> 23138393

EphB4 is overexpressed in gliomas and promotes the growth of glioma cells.

Tao Chen1, Xiaoyu Liu, Shanghui Yi, Jiannan Zhang, Jianwei Ge, Zhigang Liu.   

Abstract

Glioma is one of the most common solid tumors, and the molecular mechanism for this disease is poorly understood. EphB4 tyrosine kinase receptor has been involved in various physiologic and pathologic processes, and the role of EphB4 in tumorigenesis has recently attracted much interest. However, its function in glioma remains largely unknown. In this study, we explored the function of EphB4 in glioma. We found that the expression of EphB4 was significantly upregulated in clinical glioma samples. Overexpression of EphB4 in glioma cell lines accelerated cell growth and tumorigenesis. In contrast, downregulation of EphB4 inhibited cell growth. Furthermore, we showed that EphB4 promoted cell growth by promoting EGFR signaling. Taken together, our findings suggest that EphB4 plays an important role in the progression of glioma by stimulating cell growth and EphB4 might be a potential therapeutic target for glioma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138393     DOI: 10.1007/s13277-012-0560-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  17 in total

1.  Integrating molecular diagnostics into anticancer drug discovery.

Authors:  István Peták; Richárd Schwab; László Orfi; László Kopper; György Kéri
Journal:  Nat Rev Drug Discov       Date:  2010-06-07       Impact factor: 84.694

2.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Authors:  S Ram Kumar; Jasbir Singh; Guangbin Xia; Valery Krasnoperov; Loubna Hassanieh; Eric J Ley; Jeffrey Scehnet; Neil G Kumar; Debra Hawes; Michael F Press; Fred A Weaver; Parkash S Gill
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee.

Authors: 
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

4.  Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.

Authors:  Xinping Tan; Udayan Apte; Amanda Micsenyi; Emorphia Kotsagrelos; Jian-Hua Luo; Sarangarajan Ranganathan; Dulabh K Monga; Aaron Bell; George K Michalopoulos; Satdarshan P S Monga
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

6.  The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization.

Authors:  Nai-Ying Yang; Elena B Pasquale; Laurie B Owen; Iryna M Ethell
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

7.  Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.

Authors:  Ruth Ho; Jane E Minturn; Tomoro Hishiki; Huaqing Zhao; Qun Wang; Avital Cnaan; John Maris; Audrey E Evans; Garrett M Brodeur
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

8.  EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.

Authors:  J-J Li; D-P Liu; G-T Liu; D Xie
Journal:  Oncogene       Date:  2009-03-09       Impact factor: 9.867

9.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Authors:  Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

Review 10.  Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system.

Authors:  J Zhang; Se Hughes
Journal:  J Pathol       Date:  2006-03       Impact factor: 7.996

View more
  9 in total

1.  The role of EphB4 and IGF-IR expression in breast cancer cells.

Authors:  Gena Huang; Man Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.

Authors:  Jianquan Zhao; Chun Yang; Shujun Guo; Yonggang Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.

Authors:  Inan Olmez; Wangzhen Shen; Hayes McDonald; Bulent Ozpolat
Journal:  J Cell Mol Med       Date:  2015-03-19       Impact factor: 5.310

Review 4.  Eph receptors as therapeutic targets in glioblastoma.

Authors:  B W Day; B W Stringer; A W Boyd
Journal:  Br J Cancer       Date:  2014-08-21       Impact factor: 7.640

Review 5.  Erythropoietin Pathway: A Potential Target for the Treatment of Depression.

Authors:  Chongyang Ma; Fafeng Cheng; Xueqian Wang; Changming Zhai; Wenchao Yue; Yajun Lian; Qingguo Wang
Journal:  Int J Mol Sci       Date:  2016-05-06       Impact factor: 5.923

6.  EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.

Authors:  Christian Uhl; Moritz Markel; Thomas Broggini; Melina Nieminen; Irina Kremenetskaia; Peter Vajkoczy; Marcus Czabanka
Journal:  Angiogenesis       Date:  2018-07-10       Impact factor: 9.596

7.  Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma.

Authors:  Pierluigi Scalia; Giuseppe Pandini; Vincenzo Carnevale; Antonio Giordano; Stephen J Williams
Journal:  Oncogene       Date:  2019-07-03       Impact factor: 9.867

Review 8.  EphrinB2-EphB4 Signaling in Neurooncological Disease.

Authors:  Andras Piffko; Christian Uhl; Peter Vajkoczy; Marcus Czabanka; Thomas Broggini
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

9.  Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.

Authors:  Xin-Min Yu; Yi-Chen Wu; Xiang Liu; Xian-Cong Huang; Xiu-Xiu Hou; Jiu-Li Wang; Xiang-Liu Cheng; Wei-Min Mao; Zhi-Qiang Ling
Journal:  Int J Mol Sci       Date:  2016-11-05       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.